Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

British Public Putting Their Eyesight At Risk
- Nearly two thirds (59%) of the British public are neglecting
generic viagra online
AFRESA(R) Phase 3 Pulmonary Function Safety Data In Patients With Diabetes Presented At ADA
AFRESA® (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin with changes in pulmonary function tests comparable to usual antidiabetic treatment, according to data presented today at the American Diabetes Association"s 69th Scientific Sessions. Results from the prospective, multicenter, phase 3 study conducted over a two-year period showed no difference in mean change in forced expiratory volume in one second (FEV1) between those treated with AFRESA and those treated with standard insulin therapy.
News of the day
DeCODE-led Megastudy Finds New Genetic Clues To Causes Of Schizophrenia
The largest study of the genetics of schizophrenia ever undertaken has revealed several new common single-letter variants in the sequence of the human genome (SNPs) linked to risk of the disease. The study, by a multinational consortium of scientists led by a team from deCODE genetics (Nasdaq: DCGN), analyzed the genomes of more than 50,000 patients and control participants from fourteen countries. It is published today in the online edition of Nature.
Oncology

Arizona ADAP Cuts Number Of Medications Covered Under Program

The Arizona AIDS Drug Assistance Program (ADAP) has reduced the number of medications it will cover - antiretrovirals and drugs that treat opportunistic infections will not be affected, the Arizona Daily Star reports. The program relies heavily on federal funding. Judy Norton, chief of the state"s Office of HIV, STD and Hepatitis C Services, said the state received $2.3 million less than what it requested from the federal government, requiring the program to make cuts. According to the Daily Star, federal ADAP funds are "drying up as drug costs rise and as more" people living with HIV/AIDS are enrolling in the program. The Arizona ADAP has been serving about 1,100 patients statewide, although the number has gone up in recent months, Laura Oxley, Arizona Department of Health Services spokesperson, said. A letter explaining the changes to the program was sent to clients and providers earlier this week (Innes, Arizona Daily Star, 6/11). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009